- Operatie bij endometriose verlaagt risico op eierstokkanker

Vrouwen die een chirurgische behandeling ondergaan voor endometriose hebben een lagere kans op eierstokkanker, dan de vrouwen die dit niet doen.
Foto: ANP
Dat stellen onderzoekers in het Acta Obstetricia et Gynecologica Scandinavica, een tijdschrift van de Nordic Federation of Societies of Obstetrics and Gynecology.
Eerder onderzoek liet een verhoogd risico zien op verschillende kankers waaronder eierstokkanker, bij vrouwen met endometriose.
"Vrouwen met endometriose worden vaak behandeld met hormonen of een operatie", legt onderzoeker Anna-Sofia Melin van het Karolinska Instituut uit. "We wilden kijken of het type behandeling invloed heeft op het kankerrisico."
Zweden
De onderzoekers maakten gebruik van het Zweedse nationale patiƫntenregister en bestudeerden de gegevens van alle vrouwen die de diagnose endometriose kregen in de periode 1969 tot 2007.
In totaal hadden ze van 220 vrouwen met endometriose die eierstokkanker ontwikkelden alle gegevens, 416 vrouwen met endometriose golden als controlegroep.
ResultatenDe resultaten wijzen op een verband tussen het chirurgisch verwijderen van een eierstok en het risico op eierstokkanker. Daarnaast vonden de onderzoeker ook een verband tussen de kanker en het verwijderen van alle zichtbare endometriose.
"Die operatie lijkt vrouwen met endometriose dus te beschermen tegen eierstokkanker", aldus Melin. "De rol van een hormonale behandeling bij vrouwen met endometriose blijft onduidelijk en vervolgonderzoek is nodig."
Door: Gezondheidsnet
Bron: http://www.eurekalert.org/pub_releases/2013-04/w-etl040913.php

Endometriosis treatments lower ovarian cancer risk

A novel study shows women who undergo surgical treatment for endometriosis have a lower risk of developing ovarian cancer. According to results published in Acta Obstetricia et Gynecologica Scandinavica, a journal of the Nordic Federation of Societies of Obstetrics and Gynecology, hormonal treatments for endometriosis did not lower ovarian cancer risk.
Endometriosis is a common, and often painful, gynecological disease where tissue normally found inside the uterus, grows elsewhere in the body. According to the World Health Organization this estrogen-dependent disease affects roughly 14% of women of childbearing age. The National Institutes of Health (NIH) estimates that more than 5.5 million women in North America have endometriosis, and if left untreated can cause infertility in up to 40% of women who are unable to conceive.
Prior research shows an increased risk of several cancers, including ovarian cancer, in women with endometriosis. Some studies have found a protective effect against ovarian cancer with surgical interventions, such as hysterectomy or tubal ligation. Lead author, Dr. Anna-Sofia Melin from the Karolinska Institute and Karolinska University Hospital in Stockholm, Sweden explains, "Patients with endometriosis are typically treated with hormones, or in more severe cases, with surgery. We wanted to expand understanding of ovarian cancer risk in women with endometriosis who had some type of surgery or hormone therapy."
Using the National Swedish Patient Register, the team identified women diagnosed with endometriosis between 1969 and 2007. The National Swedish Cancer Register was then used to link women who were diagnosed with epithelial ovarian cancer at least one year following a diagnosis of endometriosis. Information on hormonal and surgical treatments was taken from medical records of the 220 women with endometriosis and ovarian cancer (cases) and 416 women with endometriosis only (controls).
Findings indicate a significant association between the surgical removal of an ovary (oophorectomy) and ovarian cancer risk. A significant link between ovarian cancer risk and radical removal of all visible endometriosis was also found. "Our study suggests that surgical removal of an ovary and removal of visible endometriosis protects women from developing ovarian cancer at a later point," concludes Dr. Melin. "For women with endometriosis, the role of hormonal treatment and future ovarian cancer risk remains unclear and further investigation is warranted."
###
This study is published in Acta Obstetricia et Gynecologica Scandinavica. Media wishing to receive a PDF of the article may contact sciencenewsroom@wiley.com.
Full citation: Hormonal and Surgical Treatments for Endometriosis and Risk of Epithelial Ovarian Cancer." Anna-Sofia Melin, Cecilia Lundholm, Ninoa Malki, Marja-Liisa Swahn, Par Sparen and Agneta Bergqvist. Acta Obstetricia et Gynecologica Scandinavica; Published online: April 11, 2013 (DOI: 10.1111/aogs.12123)
Author Contact: To arrange an interview with Dr. Melin, please contact Katarina Sternudd with Karolinska Institute at Katarina.sternudd@ki.se.
About the Journal:Acta Obstetricia et Gynecologica Scandinavica is the official scientific journal of the Nordic Federation of Societies of Obstetrics and Gynecology (NFOG). It is a clinically oriented journal that covers all aspects of obstetrics, gynecology and reproductive health, including perinatology, gynecologic endocrinology, female urology and gynecologic oncology. The journal is published in English and includes: editors´ messages, editorials, Acta commentaries, Acta reviews and original articles under the main categories of investigation, pregnancy, birth, fertility, infection, gynecology, gynecologic urology, oncology and surgery. The journal is published by Wiley on behalf of the NFOG. For more information, please visit http://wileyonlinelibrary.com/journal/aogs.